UPDATE 1-US natgas prices ease on mild forecasts and low heating demand Hurricane Rafael causing curtailment of Gulf of Mexico output NYMEX open interest hits record high for sixth day in a row Utilities expected to keep filling storage through late November Adds latest prices By Scott DiSavino Nov 8 (Reuters) - U.S. natural gas futures eased about 1% on Friday on forecasts for the weather to remain mild through late November, keeping heating demand low and allowing utilities to keep injecting m

AstraZeneca PLC expected to post earnings of $1.03 a share - Earnings Preview AstraZeneca PLC AZN.OQ , AZN.O is expected to show a rise in quarterly revenue when it reports results on November 12 for the period ending September 30 2024 The Cambridge United Kingdom-based company is expected to report a 13.9% increase in revenue to $13.088 billion from $11.49 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

BUZZ-U.S. STOCKS ON THE MOVE-Bank of America, Lucid, Pinterest Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a muted open on Friday, as a rally powered by a sweeping Trump win and an expected interest-rate cut paused after lifting the S&P 500 futures above the 6,000 mark for the first time.

DIARY-UK corporate earnings week ahead Nov 8 (Reuters) - Diary of U.K (.FTSE) corporate earnings for the week ahead UK EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 12-Nov-2024 BMO DCC.L DCC PLC Half Year 2025 DCC PLC Earnings Release 12-Nov-2024 02:00 AZN.L AstraZeneca PLC Q3 2024 AstraZeneca PLC Earnings Release 12-Nov-2024 02:00 VOD.L Vodafone Group PLC Half Year 2025 Vodafone Group PLC Earnings Release 13-Nov-2024 NTS ICGIN.L Intermediate Capital Group PLC Half Year 2025 In

BUZZ-AstraZeneca rises after asthma medicine meets primary goals in Phase 3 trial ** Shares of AstraZeneca AZN.L up 1.8% at 9,900p - among the top gainers on FTSE 100 .FTSE index ** Drugmaker's asthma medicine Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial for patients with chronic rhinosinusitis with nasal polyps ** Tezspir

BRIEF-AstraZeneca Says Tezspire Nasal Polyps Trial Met Primary Endpoints Nov 8 (Reuters) - AstraZeneca PLC AZN.L : TEZSPIRE NASAL POLYPS TRIAL MET PRIMARY ENDPOINTS TEZSPIRE SHOWS SIGNIFICANT REDUCTION IN NASAL POLYP SIZE AND CONGESTION TEZSPIRE SAFETY PROFILE CONSISTENT WITH KNOWN MEDICINE PROFILE Source text: ID:nRSH5082La Further company coverag

Health Rounds: Medication abortion is safe before 6 weeks of pregnancy Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here . By Nancy Lapid Nov 7 (Reuters) - Hello Health Rounds Readers! While medication abortion has faced legal challenges in the U.S., it is considered safe and effective, and today we have a study that found this to be the case even before six weeks of pregnancy.

UPDATE 2-US natgas prices slide 2% as mild weather keeps storage injections high Storage injections bigger than usual for 3rd week in a row Hurricane Rafael turns toward Mexico, away from U.S. Gulf Coast U.S. weather to remain mild through at least late November Adds latest prices By Scott DiSavino Nov 7 (Reuters) - U.S. natural gas futures slid about 2 % on Thursday on forecasts for the weather to remain mild through late November, which should keep heating demand low and allow utilities to inj

US natgas prices ease ahead of federal storage report By Scott DiSavino Nov 7 (Reuters) - U.S. natural gas futures eased about 1% on Thursday ahead of a federal report expected to show that mild weather last week allowed utilities to add more gas into storage for a third week in a row for the first time since October 2023. Analysts forecast U.S. utilities added 65 billion cubic feet (bcf) of gas into storage during the week ended Nov.

Xanax maker Viatris beats quarterly estimates on demand for new generic drugs Nov 7 (Reuters) - Drugmaker Viatris VTRS.O beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.5% premarket. Sales at Viatris' generic business have been boosted by new products such as Breyna, a cheaper version of AstraZeneca's AZN.L asthma inhaler Symbicort, and lisdexamfetamine, a generic

PRESS DIGEST - Wall Street Journal - Nov. 7 Nov 7 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Blackstone Real Estate entered into an agreement to take Retail Opportunity Investments Corp ROIC.O private in an all-cash transaction valued at about $4 billion, including debt.

PRESS DIGEST-British Business - Nov 7 Nov 7 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - AstraZeneca AZN.L said on Wednesday its China president Leon Wang had been detained by Chinese authorities, and although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.

PRESS DIGEST- Financial Times - Nov 7 Nov 7 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - AstraZeneca's top China executive detained by authorities - UK competition regulator drops Unilever investigation into "green" claims - JD Wetherspoon warns of near £60mn jump in taxes and costs following UK Budget - Reeves insists she will not be "coming back with more tax increases" Overview

UPDATE 1-US natgas prices climb 3% on output decline, higher demand forecasts Adds closing prices, analyst quote By Scott DiSavino Nov 6 (Reuters) - U.S. natural gas futures climbed about 3 % on Wednesday on a drop in daily output so far this month due to pipeline issues and the evacuation of some oil and gas platforms in the Gulf of Mexico ahead of Hurricane Rafael, and on forecasts for slightly cooler weather and higher heating demand next week than previously expected.

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EST Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +13.9% GlobalFoundries Inc GFS.OQ +11.9% Old Dominion Freight Line Inc ODFL.OQ +10.7% CSX Corp CSX.OQ +8.9% Baker Hughes Co BKR.OQ +7.9% Bottom Performers Percent Change Super Micro Computer Inc SMCI.OQ -23.2% Dollar Tree Inc DLTR.OQ -7.2% Mondelez International Inc MDLZ.OQ -3.6% Moderna Inc MRNA.OQ -3.4% AstraZeneca PLC AZN.OQ -3.3% The Nasdaq 100 .NDX gained 43

BUZZ-Top of the Street: Elisa, Burberry, Astrazeneca A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays upgrades Finnish telecoms group Elisa ELISA.HE to "overweight" from "underweight" on expectations of solid service revenue growth from upselling in a Finnish market viewed as the strongest in Europe ** Berenberg raises Swiss semiconductor and vacuum solutions company Inficon Holding IFCN.S to "buy" from "hold", saying that recent share price corr

UPDATE 5-AstraZeneca's China chief in custody, believes unrelated to insurance probe Company says China president in custody, doesn't know why Says to its knowledge the issue is separate to insurance probe China also investigating four staff over Hong Kong imports Shares down 1.9% after big fall on Tuesday Recasts, updates shares in paragraph 8, adds details on third probe in 13 and 14, investor briefing details in 15 and 16 By Maggie Fick LONDON, Nov 6 (Reuters) - AstraZeneca AZN.L said on Wedn

US natgas prices edge up 1% on output decline, higher demand forecasts By Scott DiSavino Nov 6 (Reuters) - U.S. natural gas futures edged up about 1% on Wednesday on a drop in daily output so far this month due to pipeline issues and the evacuation of some oil and gas platforms in the Gulf of Mexico ahead of Hurricane Rafael, and on forecasts for slightly cooler weather and higher heating demand next week than previously expected.

AstraZeneca: China's investigation into exec separate from medical insurance probe LONDON, Nov 6 (Reuters) - AstraZeneca AZN.L said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive, Leon Wang, is separate from a large health insurance fraud case also involving the company. The company said its Chief Financial Officer Aradhana Sarin had briefed investors on the subject on Wednesday to quell concerns about the fraud probe expanding

BUZZ-AstraZeneca recoups from previous session's losses over China probe concerns ** Shares of AstraZeneca AZN.L rise as much as 2.6% to 10,378p ** In the previous session, stock fell over 8% on China probe concerns ** Dozens of senior executives at AstraZeneca China are expected to be implicated in the largest insurance fraud case in the nation's